🇮🇳 NExT · subject

NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences) Syllabus

The Pathology, Pharmacology and Microbiology (Para-clinical Sciences) syllabus for NExT in full: 6 chapters, 24 topics and 18 sub-topics, every one listed below, plus 51 Pathology, Pharmacology and Microbiology (Para-clinical Sciences) flashcards with answers.

6Chapters
24Topics
18Sub-topics
51Flashcards

Pathology, Pharmacology and Microbiology (Para-clinical Sciences) syllabus: all 6 chapters

Expand any chapter to see its topics and sub-topics.

  1. General and Systemic Pathology

    5 topics
    • Cell Injury, Inflammation and Repair
      • Necrosis, apoptosis, acute and chronic inflammation
    • Neoplasia
      • Carcinogenesis, tumor markers, metastasis
    • Hemodynamic Disorders
      • Thrombosis, embolism, infarction, edema
    • Immunopathology and Amyloidosis
    • Systemic Pathology Correlations
      • Organ-specific lesions across systems
  2. Hematology and Clinical Pathology

    3 topics
    • Laboratory Hematology
      • Peripheral smear, CBC interpretation
    • Coagulation and Transfusion Medicine
      • Blood grouping, cross-matching, transfusion reactions
    • Urinalysis and Body Fluid Examination
  3. General Pharmacology and Pharmacokinetics

    4 topics
    • Pharmacokinetics and Pharmacodynamics
      • Absorption, distribution, metabolism, excretion
      • Receptor theory, dose-response, agonist/antagonist
    • Adverse Drug Reactions and Pharmacovigilance
    • Routes of Administration and Drug Interactions
    • Rational Drug Use and Essential Medicines
  4. Systemic and Clinical Pharmacology

    5 topics
    • Autonomic Nervous System Drugs
      • Cholinergics, adrenergics and antagonists
    • Cardiovascular and Renal Pharmacology
      • Antihypertensives, diuretics, antianginals
    • CNS Pharmacology
      • Sedatives, antiepileptics, antipsychotics, opioids
    • Antimicrobial Chemotherapy
      • Antibiotics, antivirals, antifungals, AMR
    • Chemotherapy and Hormonal Agents
  5. General Microbiology and Immunology

    3 topics
    • Bacterial Structure, Sterilization and Disinfection
    • Immunology
      • Innate and adaptive immunity, hypersensitivity
      • Vaccines and immunodiagnostics
    • Host-Parasite Relationship and Infection Control
  6. Systematic Microbiology

    4 topics
    • Medical Bacteriology
      • Gram-positive and gram-negative pathogens
      • Mycobacteria and spirochetes
    • Virology
      • Hepatitis viruses, HIV, respiratory viruses
    • Mycology and Parasitology
      • Systemic mycoses, protozoa, helminths
    • Clinical Microbiology and Lab Diagnosis

NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences) flashcards — 51 questions with answers

  1. What are the two main types of cellular adaptation involving size, and how do they differ?

    Hypertrophy is an increase in cell size (and organ size) due to increased synthesis of structural components, occurring in non-dividing cells like cardiac/skeletal muscle. Hyperplasia is an increase in the number of cells, occurring only in tissues capable of division (e.g., endometrium, liver).

  2. What is the key biochemical difference between reversible and irreversible cell injury?

    Reversible injury shows ATP depletion, cellular swelling, and ribosomal detachment but intact membranes. Irreversible injury is marked by severe membrane damage (mitochondrial, lysosomal, plasma) and profound mitochondrial dysfunction with massive calcium influx; the two hallmarks are inability to reverse mitochondrial dysfunction and membrane function loss.

  3. Name the morphological patterns of necrosis and a classic example of each.

    Coagulative (ischemia/MI), liquefactive (brain infarct, abscess), caseous (TB), fat necrosis (acute pancreatitis), fibrinoid (immune vasculitis/malignant hypertension), and gangrenous (limb ischemia).

  4. What are the two pathways of apoptosis and their key triggers?

    The intrinsic (mitochondrial) pathway is triggered by cell stress/DNA damage via Bcl-2 family proteins releasing cytochrome c. The extrinsic (death receptor) pathway is triggered by ligands like FasL/TNF binding death receptors (Fas/TNFR1). Both converge on executioner caspases (3, 6, 7).

  5. What is the difference between dystrophic and metastatic calcification?

    Dystrophic calcification occurs in damaged/necrotic tissue with normal serum calcium levels (e.g., atheromas, TB lesions). Metastatic calcification occurs in normal tissue due to hypercalcemia (e.g., hyperparathyroidism, vitamin D toxicity, renal failure).

  6. What are the five cardinal signs of acute inflammation and their Latin terms?

    Redness (rubor), heat (calor), swelling (tumor), pain (dolor), and loss of function (functio laesa).

  7. List the sequential steps of leukocyte extravasation in acute inflammation.

    Margination and rolling (selectins), adhesion (integrins binding ICAM-1/VCAM-1), transmigration/diapedesis (PECAM-1/CD31), and chemotaxis toward the injury (e.g., C5a, LTB4, IL-8, bacterial products).

  8. What are the major chemical mediators of vasodilation and increased vascular permeability in inflammation?

    Vasodilation: histamine, prostaglandins (PGI2, PGE2), and nitric oxide. Increased permeability: histamine, bradykinin, leukotrienes (C4, D4, E4), and substance P.

  9. Distinguish healing by primary intention from secondary intention.

    Primary intention: clean, approximated wound edges (e.g., surgical incision) with minimal tissue loss, little granulation tissue, and a thin scar. Secondary intention: large gaping wounds with extensive tissue loss, abundant granulation tissue, significant wound contraction, and a larger scar.

  10. What growth factor is most important in angiogenesis, and which cell deposits collagen in repair?

    VEGF (vascular endothelial growth factor) drives angiogenesis. Fibroblasts (and myofibroblasts) deposit collagen and extracellular matrix; myofibroblasts also mediate wound contraction.

  11. What is the difference between a benign and malignant neoplasm in terms of nomenclature suffixes?

    Benign tumors generally end in '-oma' (e.g., adenoma, lipoma). Malignant tumors of epithelial origin are 'carcinomas' and those of mesenchymal origin are 'sarcomas.' Exceptions like lymphoma, melanoma, and seminoma are malignant despite the '-oma' suffix.

  12. Define anaplasia and list its cytologic features.

    Anaplasia is lack of differentiation, a hallmark of malignancy. Features: pleomorphism (variation in cell/nuclear size and shape), hyperchromatic nuclei with high nuclear-to-cytoplasmic ratio, prominent nucleoli, abnormal/atypical mitoses, and loss of polarity.

  13. What is the difference between an oncogene and a tumor suppressor gene, with an example of each?

    Oncogenes are mutated proto-oncogenes that promote growth and are dominant (one allele mutation suffices), e.g., RAS, MYC. Tumor suppressor genes inhibit growth and are typically recessive (both alleles must be lost—'two-hit hypothesis'), e.g., TP53, RB.

  14. Define metastasis and name the most common routes of spread for carcinomas versus sarcomas.

    Metastasis is the spread of tumor to discontinuous distant sites, the most reliable marker of malignancy. Carcinomas typically spread via lymphatics; sarcomas typically spread hematogenously (via blood).

  15. List the steps of the metastatic cascade.

    Invasion of basement membrane → loosening of cell-cell contacts (E-cadherin loss) → degradation of ECM (matrix metalloproteinases) → migration → intravasation into vessels → survival in circulation → extravasation → formation of micrometastasis → colonization at the distant site.

  16. What are the key differences between an exudate and a transudate?

    Exudate: high protein (>2.9 g/dL), specific gravity >1.020, high LDH, cloudy, due to inflammation/increased vascular permeability. Transudate: low protein, specific gravity <1.012, clear, due to hydrostatic/oncotic pressure imbalance (e.g., heart failure, hypoalbuminemia).

  17. What is Virchow's triad for thrombosis?

    The three factors predisposing to thrombus formation: (1) endothelial injury, (2) abnormal blood flow (stasis or turbulence), and (3) hypercoagulability.

  18. Differentiate a red (hemorrhagic) infarct from a white (anemic) infarct.

    Red infarcts occur in loose tissues with dual blood supply or venous occlusion (e.g., lung, intestine), with hemorrhage into necrotic zone. White infarcts occur in solid organs with end-arterial supply (e.g., heart, spleen, kidney) where dense tissue limits hemorrhage.

  19. What characterizes the different types of shock (hypovolemic, cardiogenic, septic)?

    Hypovolemic: reduced blood/plasma volume (hemorrhage, burns). Cardiogenic: pump failure (MI, arrhythmia, tamponade). Septic: systemic vasodilation and pooling from infection (often gram-negative endotoxin), causing warm shock initially with high output and low resistance.

  20. What are the four types of hypersensitivity reactions (Gell and Coombs)?

    Type I: immediate/anaphylactic (IgE-mediated, e.g., asthma, anaphylaxis). Type II: antibody-mediated/cytotoxic (IgG/IgM against cell antigens, e.g., hemolytic anemia). Type III: immune complex-mediated (e.g., SLE, serum sickness). Type IV: delayed/cell-mediated (T cells, e.g., TB skin test, contact dermatitis).

Show the other 31 Pathology, Pharmacology and Microbiology (Para-clinical Sciences) flashcards
  1. What is amyloid, and which stain confirms it with what characteristic appearance?

    Amyloid is an abnormal extracellular deposit of misfolded proteins in beta-pleated sheet configuration. Congo red stain shows apple-green birefringence under polarized light. Common types: AL (light chains, plasma cell dyscrasias) and AA (serum amyloid A, chronic inflammation).

  2. What are Reed-Sternberg cells and which disease are they diagnostic of?

    Reed-Sternberg cells are large binucleate or multinucleate cells with prominent eosinophilic nucleoli ('owl-eye' appearance), CD15+ and CD30+. They are the hallmark malignant cell of Hodgkin lymphoma.

  3. List the indices used in classifying anemias and how MCV categorizes them.

    MCV (mean corpuscular volume), MCH, MCHC, and RDW. By MCV: microcytic (<80 fL, e.g., iron deficiency, thalassemia), normocytic (80–100 fL, e.g., acute blood loss, anemia of chronic disease), and macrocytic (>100 fL, e.g., B12/folate deficiency).

  4. What peripheral smear findings characterize iron deficiency anemia versus megaloblastic anemia?

    Iron deficiency: microcytic, hypochromic RBCs with increased central pallor, anisopoikilocytosis, pencil cells, target cells. Megaloblastic anemia: macro-ovalocytes and hypersegmented neutrophils (>5 lobes).

  5. What is the normal hemoglobin electrophoresis pattern in an adult, and what changes in beta-thalassemia major?

    Normal adult: HbA (alpha2beta2) ~95–97%, HbA2 (alpha2delta2) ~2–3%, HbF (alpha2gamma2) <1%. In beta-thalassemia major: markedly reduced/absent HbA, with elevated HbF and HbA2.

  6. Describe the extrinsic, intrinsic, and common coagulation pathways and the tests that assess them.

    Extrinsic pathway (factor VII, tissue factor) is assessed by PT/INR. Intrinsic pathway (factors XII, XI, IX, VIII) is assessed by aPTT. Both converge on the common pathway (factors X, V, II/prothrombin, I/fibrinogen). Thrombin time assesses fibrinogen-to-fibrin conversion.

  7. What clotting factors are vitamin K-dependent, and which anticoagulant inhibits them?

    Factors II, VII, IX, and X (plus proteins C and S) are vitamin K-dependent (require gamma-carboxylation). Warfarin inhibits vitamin K epoxide reductase, depleting these functional factors; monitored by PT/INR.

  8. What are the major ABO blood group compatibility rules for RBC transfusion?

    Group O is the universal RBC donor (no A/B antigens); group AB is the universal recipient (no anti-A/anti-B antibodies). Recipients must not receive RBCs bearing antigens against which they have antibodies, e.g., a group A patient has anti-B antibodies and cannot receive B or AB blood.

  9. Differentiate acute hemolytic transfusion reaction from febrile non-hemolytic transfusion reaction.

    Acute hemolytic reaction: usually ABO incompatibility, complement-mediated intravascular hemolysis with fever, flank pain, hemoglobinuria, hypotension/DIC—a medical emergency. Febrile non-hemolytic reaction: most common, caused by recipient antibodies against donor leukocyte antigens/cytokines, presenting as fever/chills without hemolysis.

  10. What casts in urinalysis indicate glomerulonephritis, acute tubular necrosis, and pyelonephritis respectively?

    RBC casts indicate glomerulonephritis (glomerular bleeding). Muddy-brown granular (epithelial) casts indicate acute tubular necrosis. WBC casts indicate pyelonephritis/tubulointerstitial inflammation.

  11. What does urine dipstick positivity for nitrites and leukocyte esterase suggest, and what is the limitation of nitrites?

    Both suggest urinary tract infection: leukocyte esterase indicates pyuria (WBCs), and nitrites indicate bacteria that reduce nitrate to nitrite (e.g., E. coli, gram-negative Enterobacteriaceae). Limitation: gram-positive organisms and Pseudomonas may not reduce nitrate, giving false-negative nitrites.

  12. Define bioavailability and first-pass metabolism.

    Bioavailability (F) is the fraction of an administered dose that reaches systemic circulation unchanged; it is 100% for IV drugs. First-pass metabolism is the metabolism of an orally administered drug in the gut wall and liver before reaching systemic circulation, reducing oral bioavailability.

  13. Give the formulas for volume of distribution, clearance, and elimination half-life.

    Vd = amount of drug in body / plasma concentration. Clearance (CL) = rate of elimination / plasma concentration. Half-life t1/2 = (0.693 × Vd) / CL. Half-life determines dosing interval and time to steady state (~4–5 half-lives).

  14. What is the difference between zero-order and first-order kinetics?

    First-order kinetics: a constant fraction of drug is eliminated per unit time (rate proportional to concentration); most drugs follow this. Zero-order kinetics: a constant amount is eliminated per unit time (saturable enzymes), e.g., ethanol, phenytoin (high dose), aspirin (high dose).

  15. Define potency versus efficacy and the meaning of ED50, LD50, and therapeutic index.

    Potency is the amount of drug needed for a given effect (reflected by EC50/ED50). Efficacy is the maximal effect a drug can produce (Emax). ED50 is the dose effective in 50% of subjects; LD50 is the dose lethal in 50%. Therapeutic index = LD50/ED50; a higher TI means a safer drug.

  16. Distinguish a competitive antagonist from a non-competitive antagonist on a dose-response curve.

    A competitive (reversible) antagonist shifts the agonist dose-response curve rightward (increased EC50) but keeps Emax the same—surmountable with more agonist. A non-competitive (irreversible) antagonist reduces Emax and is not overcome by more agonist—insurmountable.

  17. What are the WHO/Rawlins-Thompson types of adverse drug reactions (Type A and Type B)?

    Type A (Augmented): dose-dependent, predictable, related to the drug's known pharmacology, common, low mortality (e.g., bleeding with warfarin). Type B (Bizarre): dose-independent, unpredictable, not related to known pharmacology, rare, higher mortality (e.g., anaphylaxis, idiosyncratic reactions).

  18. What is pharmacovigilance and what is a 'black triangle' / yellow card concept?

    Pharmacovigilance is the science of detecting, assessing, understanding, and preventing adverse drug effects. The yellow card system (and equivalents) is a spontaneous ADR reporting mechanism; the black triangle marks newer drugs under intensive/additional monitoring.

  19. Compare the major routes of drug administration: IV, oral, and sublingual in terms of onset and first-pass effect.

    IV: immediate onset, 100% bioavailability, no first-pass effect. Oral: slow/variable onset, subject to first-pass metabolism, convenient. Sublingual: rapid onset, bypasses first-pass metabolism (drains to systemic veins), e.g., glyceryl trinitrate for angina.

  20. What is the difference between a pharmacokinetic and a pharmacodynamic drug interaction, with an example of each?

    Pharmacokinetic interactions alter absorption, distribution, metabolism, or excretion (e.g., rifampin inducing CYP enzymes lowers warfarin levels). Pharmacodynamic interactions occur at the site of action without changing concentration (e.g., additive CNS depression with alcohol plus benzodiazepines).

  21. What are the WHO criteria for a P-drug (personal drug) selection and the components of rational drug use?

    WHO P-drug criteria: efficacy, safety, suitability, and cost. Rational drug use means patients receive the right medication, in the appropriate dose, for an adequate period, at the lowest cost, and matching their clinical needs.

  22. What is the WHO Essential Medicines List and the criteria for inclusion?

    The WHO Model List of Essential Medicines lists medications that satisfy the priority health-care needs of a population. Selection criteria: relevance to disease prevalence, proven efficacy and safety, and comparative cost-effectiveness; medicines should be available at all times in adequate amounts and appropriate dosage forms.

  23. Contrast the effects of sympathetic (adrenergic) versus parasympathetic (cholinergic) stimulation on heart rate, pupils, and bronchi.

    Sympathetic: increases heart rate (beta1), dilates pupils (mydriasis, alpha1), dilates bronchi (beta2). Parasympathetic: decreases heart rate (M2), constricts pupils (miosis, M3), constricts bronchi (M3).

  24. Classify cholinergic drugs and give the antidote for organophosphate poisoning.

    Cholinergics: direct-acting (e.g., pilocarpine, bethanechol) and indirect-acting cholinesterase inhibitors (reversible: neostigmine, physostigmine; irreversible: organophosphates). Organophosphate (irreversible AChE inhibitor) poisoning is treated with atropine (muscarinic antagonist) plus pralidoxime (regenerates cholinesterase if given early).

  25. What are the main classes of antihypertensive drugs?

    Diuretics (thiazides), ACE inhibitors (e.g., enalapril), angiotensin receptor blockers (e.g., losartan), calcium channel blockers (e.g., amlodipine), beta-blockers (e.g., metoprolol), and others (alpha-blockers, central agonists, direct vasodilators).

  26. How does the mechanism of loop diuretics differ from thiazide diuretics, and where do they act?

    Loop diuretics (e.g., furosemide) inhibit the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle—most potent diuretics. Thiazides (e.g., hydrochlorothiazide) inhibit the Na-Cl cotransporter in the distal convoluted tubule—moderate efficacy and useful in hypertension.

  27. Classify antiepileptic drugs by their primary mechanism of action.

    Sodium channel blockers (phenytoin, carbamazepine, lamotrigine); GABA enhancers (benzodiazepines, barbiturates, valproate); calcium channel (T-type) blockers (ethosuximide—drug of choice for absence seizures); and multiple/novel mechanisms (levetiracetam binds SV2A, valproate has broad action).

  28. Describe the mechanism of action of penicillins and why they don't affect human cells.

    Beta-lactam antibiotics (penicillins) inhibit bacterial cell wall synthesis by binding penicillin-binding proteins (transpeptidases) and blocking peptidoglycan cross-linking; they are bactericidal. Human cells lack a peptidoglycan cell wall, so they are unaffected—providing selective toxicity.

  29. Match antibiotic classes to their mechanisms: aminoglycosides, fluoroquinolones, macrolides, and sulfonamides.

    Aminoglycosides: inhibit 30S ribosomal subunit (protein synthesis), bactericidal. Fluoroquinolones: inhibit DNA gyrase/topoisomerase. Macrolides: inhibit 50S ribosomal subunit, bacteriostatic. Sulfonamides: inhibit dihydropteroate synthase (folate synthesis), bacteriostatic.

  30. What is the difference between Gram-positive and Gram-negative bacterial cell walls, and why do they stain differently?

    Gram-positive bacteria have a thick peptidoglycan layer that retains the crystal violet–iodine complex, staining purple. Gram-negative bacteria have a thin peptidoglycan layer plus an outer lipopolysaccharide membrane; they lose the crystal violet on decolorization and take up the safranin counterstain, appearing pink/red.

  31. Differentiate sterilization from disinfection, and name a method that achieves true sterilization including spores.

    Sterilization is the complete destruction/removal of all microorganisms including bacterial spores. Disinfection eliminates most pathogenic organisms but not necessarily resistant spores. Autoclaving (moist heat at 121°C, 15 psi, 15 minutes) achieves sterilization, as do ethylene oxide gas and gamma irradiation.

NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences) FAQ

What is in the NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences) syllabus?

NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences) is split into 6 chapters: General and Systemic Pathology, Hematology and Clinical Pathology, General Pharmacology and Pharmacokinetics, Systemic and Clinical Pharmacology, General Microbiology and Immunology and Systematic Microbiology. Together they contain 24 topics and 18 sub-topics.

How many chapters are in NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences)?

6 chapters, containing 24 topics and 18 sub-topics. The largest chapter is General and Systemic Pathology, with 5 topics.

Are there flashcards for NExT Pathology, Pharmacology and Microbiology (Para-clinical Sciences)?

Yes — a 51-card Pathology, Pharmacology and Microbiology (Para-clinical Sciences) deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.